Professor, Surgery, UC, Davis School of Medicine
General Surgery
Dr. Richard J. Bold, MD
|
|
Give Review
Richard Bold is an expert in the field of General Surgery. He went to Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Doctor Richard J. Bold, MD is a published doctor. He has 99 publications published. The most current publication "Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up." Richard Bold accepts all Medicare patients.
Publications
- Predictors of financial difficulties and work modifications among Cancer survivors in the United States.
- Phase II clinical trials on investigational drugs for the treatment of pancreatic Cancers.
- Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenoCarcinoma.
- Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.
- Practice Patterns in the Delivery of Radiation Therapy After Mastectomy Among the University of California Athena Breast Health Network.
- Outcomes of Pancreaticoduodenectomy: Where Should We Focus Our Efforts on Improving Outcomes?
- Relative value units poorly correlate with measures of surgical effort and complexity.
- Mental health needs and service use in a national sample of adult Cancer survivors in the USA: has psychosocial care improved?
- Role of autophagy in apoptotic regulation by akt in pancreatic Cancer.
- Comparative morbidity and mortality from cervical or thoracic Esophageal anastomoses.
- The Potential Role of Radiation Therapy to the Primary Site of Disease in Stage IV Breast Cancer Presenting With Synchronous Metastasis.
- Extremity soft tissue Tumor surgery by surgical specialty: A comparison of case volume among oncology and non-oncology-designated surgeons.
- RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy.
- Quantitation of sentinel node metastatic burden and Her-2/neu over-expression accurately predicts residual axillary nodal involvement and extranodal disease in Breast ...
- Negligible Effect of Perioperative Epidural Analgesia Among Patients Undergoing Elective Gastric and Pancreatic Resections.
- Nomograms to predict risk of in-hospital and post-discharge venous thromboembolism after Abdominal and thoracic surgery: an American College of Surgeons National Surgi...
- Utilization of Sentinel Lymph Node Biopsy in Patients with Ductal Carcinoma In Situ Undergoing Mastectomy.
- Rural-urban disparities in use of post-Lumpectomy radiation.
- Utilization of lymph node assessment in patients with Ductal carcinoma in situ treated with lumpectomy.
- Urban and non-urban disparities in the use of post-mastectomy radiation for breast Cancer.
- Perioperative Outcomes for Open Distal Pancreatectomy: Current Benchmarks for Comparison.
- Predicting Survival for Well-Differentiated Liposarcoma: The Importance of Tumor Location.
- Do radiation use disparities influence survival in patients with advanced breast Cancer?
- Nomogram to Predict Risk of 30-Day Morbidity and Mortality for Patients With Disseminated Malignancy Undergoing Surgical Intervention.
- Surgical Resident Involvement Is Safe for Common Elective General Surgery Procedures.
- Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP Analysis.
- Factors affecting treatment delivery and outcomes of patients with early-stage pancreatic adenoCarcinoma.
- Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death.
- Survival in 12,653 breast Cancer patients with extensive axillary lymph node metastasis in the anthracycline era.
- Sacramento area breast Cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum.
- Disparities in the use of radiation therapy in patients with local-regionally advanced breast Cancer.
- Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic Cancer.
- Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the Breast.
- Finding the problems before fixing them: the culture of perioperative safety.
- Medullary carcinoma of the Breast: a population-based perspective.
- Complex diaphragm reconstruction using dermal collagen matrix after multivisceral resection of retroperitoneal sarcoma.
- Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas.
- Negligible effect of selective preoperative Biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy.
- Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a Pancreatic tumor model.
- Benefit of postoperative adjuvant therapy for pancreatic Cancer: A population-based analysis.
- ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate Cancer.
- ERK/BCL-2 pathway in the resistance of pancreatic Cancer to anoikis.
- Arginine deiminase as a novel therapy for prostate Cancer induces autophagy and caspase-independent apoptosis.
- Pancreatic Cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.
- A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast Cancer.
- Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma.
- Effect of generational composition on the surgical workforce.
- BCL-2 functions as an activator of the AKT signaling pathway in pancreatic Cancer.
- Perioperative care of the patient with hemophilia undergoing urgent appendectomy.
- Diffusion of surgical techniques in early stage breast Cancer: variables related to adoption and implementation of sentinel lymph node biopsy.
- A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal Cancer.
- Upstaging and improved survival of early breast Cancer patients after implementation of sentinel node biopsy for axillary staging.
- Re: Rectal Cancer surgery in the elderly: a multivariate analysis of outcome risk factors, by Bufalari A, Giustozzi G, Burattini MF, et al.
- Bortezomib-based combinations in the treatment of non-small-cell lung Cancer.
- Proteasome inhibition in small-cell lung Cancer: preclinical rationale and clinical applications.
- An analysis of cost and clinical outcome in palliation for advanced pancreatic Cancer.
- Experience and attitudes of surgeons toward palliation in Cancer.
- A young surgeon's perspective.
- Standardization of sentinel lymph node biopsy in Breast carcinoma.
- Immediate Breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed.
- Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic Cancer.
- Hilar cholangioCarcinoma: surgical and endoscopic approaches.
- Proteasome inhibition with PS-341 (bortezomib) in lung Cancer therapy.
- Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment.
- Surgery in the aged population: surgical oncology.
- Utility of tumor markers in determining resectability of pancreatic Cancer.
- Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic Cancer.
- Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human Pancreatic tumor xenografts.
- Modern parathyroid surgery: a cost-benefit Analysis of localizing strategies.
- Multimodality management of a giant cell Tumor arising in the proximal sacrum: case report.
- Percutaneous transhepatic portography with intravascular ultrasonography for evaluation of venous involvement of hepatoBiliary and pancreatic tumors.
- Re: Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast Cancers.
- Morbidity, mortality, and technical factors of distal pancreatectomy.
- Surgical management of breast Cancer: today and tomorrow.
- Controlled tamponade of severe presacral venous hemorrhage: use of a Breast implant sizer.
- Symptomatic Pancreatic polypeptide-secreting tumor of the distal pancreas (PPoma).
- Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric Cancer.
- Text messaging among residents and faculty in a university general surgery residency program: prevalence, purpose, and patient care.
- Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy.
- The role of Akt activation in the response to chemotherapy in pancreatic Cancer.
- The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung Cancer: a California Cancer Consortium Phase I study.
- Preoperative evaluation of pancreatic adenoCarcinoma.
- Hepatic artery aneurysm within focal nodular hyperplasia.
- Prognostic factors in resectable pancreatic Cancer: p53 and bcl-2.
- Major vascular resection as part of pancreaticoduodenectomy for Cancer: radiologic, intraoperative, and pathologic analysis.
- Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic Carcinoma is determined by Bcl-2 content.
- Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
- Bombesin stimulates in vitro growth of human breast Cancer independent of estrogen receptors status.
- Preoperative chemoradiation strategies for localized adenoCarcinoma of the pancreas.
- Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic Cancer [seecomments].
- Prospective, randomized trial of Doppler-assisted subclavian vein catheterization.
- Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection.
- Apoptosis, Cancer and Cancer therapy.
- A human gastric Cancer cell line possesses a functional receptor for gastrin-releasing peptide.
- Local rotational flaps for Breast conservation therapy as an alternative to mastectomy.
- Hyperphosphorylation of retinoblastoma protein and stimulation of growth by okadaic acid in human pancreatic Cancer.
- All-trans-retinoic acid inhibits growth of human pancreatic Cancer cell lines.
- Surgery.
Schools
Stanford University School Of Medicine
UC Davis
MD Anderson Cancer Center
Procedures Preformed
- Adrenalectomy
- Appendectomy, Open
- Biopsy of Breast
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anorectal Abscess
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of California Davis -
Stanford University School of Medicine
Hospital
-
University of California, Davis Medical Center
Drug Facts
| NPI NUMBER | 1851374441 | |
| NPPES Provider LastName | BOLD | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 958172229 | |
| NPPES Provider State | CA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 30.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851374441 |
| Last Name Of The Provider | BOLD |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Michael A. Beneke, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald W. Hause, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark E. Kromer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor M. Rodriguez, MD |
|
|
Dr. Soman Sen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joy L. Graf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron D. Carr, MD
This Doctor is OpenDoctor Recommended.
|